COMP <GO>
OSUR vs ANIK // EV/EBITDA & P/E VALUATION
OraSure Technologies Inc. (NASDAQ) VS. Anika Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: OSUR 0
— ANIK 9
■ METRIC PARITY
LAST: $4.08 (-0.49%) • MKT CAP: $281.4M
valuation
—
LAST: $21.79 (+1.11%) • MKT CAP: $291.6M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSUR VS. ANIK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OSUR | ANIK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.90% | 56.60% | -14.70 | ANIK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -10.20% | -24.80 | ANIK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -18.91% | 1.50% | -20.41 | ANIK | /fcf-yield <GO> |
| Operating Margin | -60.00% | -9.80% | -50.20 | ANIK | /operating-margins <GO> |
| Net Profit Margin | -59.80% | -9.80% | -50.00 | ANIK | /net-margins <GO> |
| Revenue Growth (YoY) | -38.10% | -5.90% | -32.20 | ANIK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.47 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 6/9 | -3.00 | ANIK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.0 | 53.1 | -1.14 | ANIK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $281.4M | $291.6M | -$10.2M | ANIK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OSUR REV | ANIK REV | OSUR GROSS % | ANIK GROSS % | OSUR FCF | ANIK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $115.0M | $112.8M | 41.9% | 56.6% | -$53.2M | $4.4M |
| FY 2024 | $185.8M | $119.9M | 42.7% | 63.4% | $23.6M | -$2.3M |
| FY 2023 | $405.5M | $120.8M | — | — | $141.6M | -$1.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSUR // BETA —
ANIK // BETA —